The epidermal growth factor receptor is involved in angiotensin II but not aldosterone/salt-induced cardiac remodelling.
Experimental and clinical studies have shown that aldosterone/mineralocorticoid receptor (MR) activation has deleterious effects in the cardiovascular system; however, the signalling pathways involved in the pathophysiological effects of aldosterone/MR in vivo are not fully understood. Several in vi...
Enregistré dans:
Auteurs principaux: | Smail Messaoudi, An Di Zhang, Violaine Griol-Charhbili, Brigitte Escoubet, Junichi Sadoshima, Nicolette Farman, Frederic Jaisser |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b89b461687e94da88897642bde4e2bc2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cardiomyopathy and response to enzyme replacement therapy in a male mouse model for Fabry disease.
par: Aurelie Nguyen Dinh Cat, et autres
Publié: (2012) -
The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
par: Eliecer Coto, et autres
Publié: (2021) -
Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease
par: Ewa Szczepanska-Sadowska, et autres
Publié: (2021) -
New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
par: Miklós Fagyas, et autres
Publié: (2014) -
COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
par: Susanne Rysz, et autres
Publié: (2021)